| mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |